Omada For Employers

Omada Health is committed to gaining a better understanding of the patient experience surrounding GLP-1 treatment for weight loss. To this end, we recently conducted an in-depth attitudinal study involving 1,000 respondents who were not Omada members and had not been diagnosed with diabetes. The purpose of this research was to identify their needs along their journey with a GLP-1. Learnings from this survey will be applied to our programs and we believe they will enhance our support for a growing number of Omada members on GLP-1 treatment. These enhancements aim to help our members achieve their weight loss goals and maintain their progress even after discontinuing GLP-1 treatment.

Unsurprisingly, cost and accessibility are key concerns and inhibitors. Interestingly, the highest stress levels occur when individuals discontinue the medication, fearing that without it, they’ll lose the tools to maintain their celebrated weight loss. We believe our survey highlights a critical finding: reaching and sustaining long-term health goals requires intervention beyond the prescribed GLP-1 medication.